Characteristics | Number/median | Percent/IQR |
---|---|---|
Demographic characteristics | ||
Male (n, %) | 42 | 61.69 |
Age (years) (median, IQR) | 4.33 | 0.76–10.67 |
Underlying conditions | ||
Hematologic malignancy (n, %) | 44 | 65.67 |
Immunosuppression (n, %) | 41 | 61.19 |
Congenital heart disease (n, %) | 14 | 20.90 |
Sources of infection | ||
Respiratory tract (n, %) | 37 | 55.22 |
Gastrointestinal tract (n, %) | 14 | 20.90 |
Unknown source (n, %) | 10 | 14.93 |
Invasive operation (n, %) | 5 | 7.46 |
Urinary tract (n, %) | 1 | 1.49 |
Drug resistant bacteria phenotypes | ||
Sulbactam resistant (n, %) | 40 | 59.70 |
Extended spectrum beta-lactamase (n, %) | 32 | 47.76 |
Cephalosporin resistant (n, %) | 15 | 22.39 |
Tazobactam resistant (n, %) | 14 | 20.90 |
Carbapenem resistant (n, %) | 7 | 10.45 |
Multidrug resistant (n, %) | 6 | 8.96 |
Aminoglycoside resistant (n, %) | 4 | 5.97 |
Empiric antimicrobial treatment | ||
Carbapenem (n, %) | 38 | 56.72 |
Fourth-generation cephalosporin (n, %) | 9 | 13.43 |
Third-generation cephalosporin (n, %) | 8 | 11.94 |
Tazobactam (n, %) | 7 | 10.45 |
Second-generation cephalosporin (n, %) | 3 | 4.48 |
Sulbactam (n, %) | 2 | 2.99 |
Length of stay before the onset of bloodstream infection (days) (median, IQR) | 13.68 | 6.59–17.53 |
Length of hospitalization stay (days) (median, IQR) | 28.96 | 20.04–42.75 |
The peak of temperature (centigrade) (median, IQR) | 39.8 | 39.3–40.1 |
Antimicrobials administrated prior to blood culture (n, %) | 28 | 41.79 |
With secondary hypoalbuminemia during hospitalization (n, %) | 22 | 32.84 |
PRISM III score (median, IQR) | 8 | 3–9 |
TTP (h) (median, IQR) | 14.12 | 12.72–16.22 |
TTAT (h) (median, IQR) | 4.52 | 0.97–14.18 |
Need for invasive mechanical ventilation (n, %) | 11 | 16.42 |
Septic shock (n, %) | 12 | 17.91 |
In-hospital mortality (n, %) | 9 | 13.43 |